Product Images Ixinity

The text describes a medical container that consists of a vial with powdered drug, a vial adapter, and a pre-filled syringe with a plunger.*

This text contains information about an intravenous medication called IXINITY. It is a recombinant coagulation factor IX with a potency range of 250 IU. It comes in a single-use vial and should only be used as directed by the package insert. This medication is only available with a prescription and is manufactured in Seattle by Aptevo BioTherapeutics LLC. The text also includes a lot number, expiration date, and potency information.*

This text provides instructions and information about the storage, use, and dosing of a medication called IXINITY. The medication is used to treat bleeding episodes in patients with hemophilia B. It contains recombinant coagulation factor IX and is administered via injection. Each vial of the medication contains 250 IU, which is reconstituted with sterile water for injection. The medication should be stored at room temperature and protected from light. Patients should not use the medication if the solution appears discolored, hazy, or if there is any leakage. The enclosed package insert provides complete dosing information and directions for use. Not-made with natural rubber latex.*

NDC 70504-0270-1 is a prescription medication called IXINITY. It contains 500 IU Range coagulation factor X, recombinant and is designed for intravenous use only. It comes in a single-use vial and requires a prescription. The U.S. License number is not readable. It is manufactured by Aptevo BioTherapeutics LLC in Seattle, WA. IXINITY is a registered trademark of Aptevo BioTherapeutics LLC. The package insert should be consulted for directions on its use.*

IXINITY is a registered trademark of Aptevo BioTherapeutics LLC, Seattle. It is a recombinant coagulation factor X supplied in vials with a sterile vial adapter, filter, and pre-filled syringe with sterile water for injection. Each vial contains approximately 500IU of recombinant factor X. It should be stored at 225°C (36-77°F) with protection from light and should not be frozen. It should also be kept out of children's reach. The solution should be inspected before injection and discarded if it shows haziness, particulate matter, discoloration, or leakage. The reconstituted product should not be refrigerated and should be discarded if unused immediately or within 3 hours. The solution contains histidine, mannitol, trehalose, sodium chloride, and polysorbate 80, but it is not made with natural rubber latex. Full dosing information and directions for use are available in the enclosed package insert.*

This is a description for a medicine with the NDC code 70504-0271-1 designed for intravenous use only. The package insert contains the directions for use. The medicine is contained in a single-use vial and its name is IXINITY, a recombinant coagulation factor IX. The medicine has a U.S. license number 2054 and a registered trademark owned by Aptevo BioTherapeutics LLC N~. The package contains 1000 IU range of the medicine.*

NDC 70504-0272-1 is a single-use vial of IXINITY, a recombinant coagulation factor IX used for intravenous use only. It has a range of 1500 1U and must be used under the directions in the package insert. It is manufactured by Aptevo BioTherapeutics LLC and has a US. License No.: 2054.*

This text is a product description for IXINITY, a coagulation factor IX recombinant drug used for injection. It is registered under Aptevo BioTherapeutics LLC and should be stored at 2:25°C, protected from light and out of reach of children. Each vial of IXINITY comes with 1500 IUs of the drug, a sterile vial adapter with a filter and a syringe filled with 5 mL of water to be mixed. Once mixed, each mL of the solution will contain approximately 300 1U/mL coagulation factor X (recombinant), histidine, mannitol, trehalose, sodium chloride and polysorbate 80. The product is available with NDC #70504-0284-5 and users should refer to the enclosed package insert for complete dosing information. The product should not be used if the solution is hazy, contains particulate matter or shows signs of discoloration or leakage. The unused portion should be discarded, and the product used within three hours of reconstitution. The product should not be refrigerated after reconstitution and is not made with natural rubber latex.*

This is a product description for IXINITY, a recombinant coagulation factor IX used for intravenous use. It comes in a single-use vial and requires a prescription. The manufacturer is Aptevo BioTherapeutics LLC, located in Seattle, WA. The product is a registered trademark of the same company. The text mentions a US license number of 2054 and a component number of 1000892.01, but no other details are provided. The potency of the product is not stated.*

This is a product description for a medication called "IXINITY®". The medication contains a recombinant coagulation factor X and is stored at 225°C. It comes in a vial and syringe with sterile water and other ingredients like histidine, mannitol, and sodium chloride. The medication is registered to Aptevo BioTherapeutics LLC and should be protected from light, thawed and not be refrigerated after reconstitution.*

IXINITY is a recombinant coagulation factor IX used intravenously. The package comes in a single-use vial for medical Rx only. Potency of the solution is 3000 1U range. The solution is manufactured and distributed by Aptevo BioTherapeutics LLC, located in Seattle, WA. The product is available with US License No.: 2054. See the package insert for usage instructions. Lot and potency information is not available in the given text. IXINITY is a registered trademark of Aptevo BioTherapeutics LLC.*

IXINITY is a coagulation factor IX (recombinant) medication for injection that is used to treat bleeding in people with Hemophilia B, a genetic disorder that causes insufficient levels of clotting factor IX. The boxed product includes one vial of IXINITY 3000 U, one 10 mL syringe pre-filled with 5 mL of sterile water for injection, and a sterile vial adaptor with filter. Each vial contains nominally 3000 U IXINITY. After reconstitution with sterile water for injection, the solution contains approximately 600 1U/mL coagulation factor IX. The reconstituted product contains histidine, mannitol, trehalose, sodium chloride, and polysorbate 80. It should be stored at 2-25°C, protected from light and should not be frozen. It should be discarded after single use and kept away from children. Use the product immediately or within three hours of reconstitution and do not refrigerate after reconstitution.*